## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence presented in the abstract; no full text, figures, tables, or supplementary materials were provided
- **Shared manuscript claim summary** The authors investigate structural and functional differences between the related transcription factors MAFA and MAFB, focusing on DNA-binding contacts, transactivation domain mutants, and C-terminal region contributions to Insulin enhancer activity, using mutagenesis, AlphaFold 2 predictions, and cooperative activity assays
- **Visible evidence base** Abstract text only; no experimental details, numerical data, statistical analyses, or structural predictions are shown
- **Missing materials affecting confidence** Full manuscript, all figures and tables, methods section, AlphaFold 2 prediction outputs, mutagenesis constructs, and assay protocols

## Reviewer
- **Overall assessment** The abstract presents a potentially interesting comparative analysis of two closely related transcription factors with relevance to islet biology. The combination of experimental mutagenesis, structural prediction, and functional assays is conceptually sound. However, the abstract alone provides insufficient detail to evaluate the rigor of the methods, the robustness of the findings, or the validity of the conclusions. Several claims, particularly those regarding structural differences and their functional consequences, are stated without supporting quantitative or statistical evidence. The work may be of interest to specialists in transcriptional regulation and diabetes biology, but the current evidence base is too limited to establish the case.
- **Who would be interested in the results, and why** Researchers studying transcription factor structure-function relationships, particularly in the context of pancreatic islet gene regulation and diabetes pathogenesis. The focus on MAFA and MAFB, which have distinct roles in insulin production, would attract investigators interested in beta-cell biology and the molecular basis of monogenic diabetes. The use of AlphaFold 2 for comparative structural analysis may also interest computational biologists.
- **Major strengths** The study addresses a relevant question about how closely related transcription factors achieve distinct regulatory functions. The combination of experimental and computational approaches is appropriate. The inclusion of pathogenic mutants adds translational relevance. The focus on C-terminal region differences is a specific and testable hypothesis.
- **Major Concerns**  
  - R1-M1  
  - R1-M2  
  - R1-M3  
  - R1-M4
- **Minor Comments**  
  - R1-m1  
  - R1-m2  
  - R1-m3
- **Technical failings that need to be addressed before the case is established** R1-M1, R1-M2, R1-M3, R1-M4
- **Assessment against Nature-style criteria**  
  - Originality: The comparative approach to MAFA and MAFB using AlphaFold 2 is somewhat novel, but the abstract does not clearly distinguish this from prior structural studies.  
  - Scientific importance: The topic is relevant to islet biology and diabetes, but the abstract does not demonstrate broad significance beyond a narrow specialist audience.  
  - Interdisciplinary readership: The work bridges structural biology and gene regulation, but the abstract is written in a way that may not engage nonspecialists.  
  - Technical soundness: Cannot be assessed from the abstract alone; no methods, controls, or statistical details are provided.  
  - Readability for nonspecialists: The abstract is dense and assumes familiarity with transcription factor biology and structural prediction tools.
- **Recommendation posture** Currently not established from the provided evidence. The abstract suggests a potentially interesting study, but the lack of experimental detail and quantitative support prevents a supportive recommendation.

### Major Concerns

- **Concern ID** R1-M1  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Evidence sufficiency  
- **Claim pointer** The abstract claims that "regions outside of the contact areas also contributed to activity" based on mutagenesis of conserved MAF protein-DNA contacts.  
- **Evidence pointer** Abstract, location not provided  
- **Concern** The abstract states that most conserved contacts were essential and that regions outside the contact areas contributed to activity, but no data are shown to quantify the magnitude of these contributions, the specific residues involved, or the assays used.  
- **Why it matters** Without quantitative data, the reader cannot assess whether the contribution of non-contact regions is biologically meaningful or within experimental noise.  
- **Resolution test** Provide specific mutagenesis data, including activity measurements for each mutant, statistical comparisons, and identification of the non-contact residues involved.

- **Concern ID** R1-M2  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Evidence sufficiency  
- **Claim pointer** The abstract claims that AlphaFold 2 revealed differences in three-dimensional organization between MAFA WT and MAFB WT, and between MAFA Ser64Phe and MAFA WT, but not between MAFB Ser70Ala and MAFB WT.  
- **Evidence pointer** Abstract, location not provided  
- **Concern** The abstract reports qualitative differences from AlphaFold 2 predictions without providing any structural metrics, confidence scores, or visual representations. The claim that differences were "revealed" is not supported by any quantitative or statistical measure.  
- **Why it matters** AlphaFold 2 predictions are computational models, and differences between models may not be biologically significant without validation or quantitative comparison.  
- **Resolution test** Provide AlphaFold 2 confidence metrics, structural alignment scores, or other quantitative measures to support the claimed differences, and ideally validate key predictions experimentally.

- **Concern ID** R1-M3  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Evidence sufficiency  
- **Claim pointer** The abstract claims that MAFA and MAFB differ in their ability to cooperatively stimulate Insulin enhancer-driven activity in the presence of other islet-enriched transcription factors.  
- **Evidence pointer** Abstract, location not provided  
- **Concern** No experimental details are given for the cooperative activity assays, including which transcription factors were used, the cell types, the reporter constructs, or the magnitude and statistical significance of the observed differences.  
- **Why it matters** Cooperative activity is a central claim of the study, and without assay details and quantitative results, the claim cannot be evaluated.  
- **Resolution test** Provide full assay descriptions, dose-response or fold-change data, statistical analyses, and appropriate controls.

- **Concern ID** R1-M4  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Evidence sufficiency  
- **Claim pointer** The abstract claims that chimeric MAFA and MAFB proteins showed that C-terminal region structural differences predicted by AlphaFold 2 greatly influenced the observed properties.  
- **Evidence pointer** Abstract, location not provided  
- **Concern** The abstract does not describe how the chimeras were constructed, which regions were swapped, or how the functional properties were measured. The causal link between predicted structural differences and functional outcomes is asserted without direct evidence.  
- **Why it matters** The conclusion that C-terminal structural differences are functionally significant is a key finding, but the abstract provides no experimental support for this causal relationship.  
- **Resolution test** Provide detailed chimera construction, functional assay results for each chimera, and structural predictions for the chimeric proteins to demonstrate that the C-terminal differences are responsible for the observed effects.

### Minor Comments

- **Concern ID** R1-m1  
- **Severity** Minor  
- **Axis** Clarity  
- **Affected element** Abstract background  
- **Evidence pointer** Abstract, location not provided  
- **Issue** The abstract states that MAFA and MAFB have "important overlapping and distinct regulatory roles" but does not specify which roles are overlapping and which are distinct.  
- **Required correction** Briefly specify the known overlapping and distinct functions to provide context for the reader.

- **Concern ID** R1-m2  
- **Severity** Minor  
- **Axis** Terminology  
- **Affected element** Abstract methods  
- **Evidence pointer** Abstract, location not provided  
- **Issue** The term "transactivation domain mutants" is used without defining the domain boundaries or the functional relevance of the specific mutations.  
- **Required correction** Define the transactivation domain and explain why Ser64Phe and Ser70Ala are considered pathogenic.

- **Concern ID** R1-m3  
- **Severity** Minor  
- **Axis** Precision  
- **Affected element** Abstract results  
- **Evidence pointer** Abstract, location not provided  
- **Issue** The phrase "dissimilarities between these proteins were also observed" is vague and does not specify the nature or direction of the differences.  
- **Required correction** Specify which protein showed greater or lesser cooperative activity and under what conditions.

## Risk / unsupported claims
- The claim that non-contact regions contribute to activity is unsupported without quantitative mutagenesis data.
- The claim that AlphaFold 2 revealed structural differences is unsupported without confidence metrics or validation.
- The claim that MAFA and MAFB differ in cooperative activity is unsupported without assay details and statistics.
- The claim that C-terminal structural differences influence function is unsupported without chimera data and structural validation.
- The pathogenic nature of the MAFA Ser64Phe and MAFB Ser70Ala mutants is stated but not referenced or explained.